NICE has published a draft updated guideline on the diagnosis and management of high blood pressure, with thousands more patients to qualify for treatment. More: NICE updates high blood pressure guidelines Source: News
read moreEuropean regulators have validated Merck’s application Bavencio for review in kidney cancer. More: EMA validates Bavencio for review in advanced RCC Source: News
read moreFDA found a third possible carcinogen in sartan drugs, triggering a new round of recalls; China released final rules for its Nasdaq-style board in a bid to attract high-tech firms like biotechs; Philippine prosecutors will charge Sanofi officials in Dengvaxia
read morePublic health officials having confirmed a sharp rise of measles across Greater Manchester, leading to renewed calls for the public to ensure they are fully vaccinated against the disease. More: 32 cases of measles confirmed in Greater Manchester Source: News
read morePatients and campaigners took to the streets in London yesterday demanding NHS access to Vertex’ cystic fibrosis drugs, following a public hearing on the situation ordered by MPs. More: Campaigners call for NHS access to Orkambi as MP inquiry gets
read moreAfter Allergan revealed Wednesday that a major pipeline prospect had flunked a phase 3 trial, analysts predicted activist investors demanding change would ratchet up pressure on the company’s executives. And it didn’t take long for those activists to prove them
read more© 1994 - 2026 B.M. Pharmaceuticals